April 17, 2009

Acorn acquired a worldwide license from a prestigious university for a novel small molecule for the treatment of glaucoma.

May 13, 2008

Acorn acquired an exclusive worldwide license from the University of Southern California for a novel technology that enables an expanding class of recombinant therapeutic proteins to be given orally.

Please check back shortly for more information regarding news and press related items.